No need to change guidelines for diabetic retinopathy and renin-angiotensin system inhibitors

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	231-232
Journal	The Lancet Diabetes & Endocrinology
Volume	3
Issue number	4
DOIs	https://doi.org/10.1016/S2213-8587(15)70006-9
Publication status	Published - Apr 2015

Access to Document

@article{2b68068c86c54481a69feca44343b658,

title = "No need to change guidelines for diabetic retinopathy and renin-angiotensin system inhibitors",

author = "{van Sloten}, {Thomas T.} and Stehouwer, {Coen D. A.}",

year = "2015",

month = apr,

doi = "10.1016/S2213-8587(15)70006-9",

language = "English",

volume = "3",

pages = "231--232",

journal = "The Lancet Diabetes & Endocrinology",

issn = "2213-8587",

publisher = "Elsevier Science",

number = "4",

}

TY - JOUR

T1 - No need to change guidelines for diabetic retinopathy and renin-angiotensin system inhibitors

AU - van Sloten, Thomas T.

AU - Stehouwer, Coen D. A.

PY - 2015/4

Y1 - 2015/4

U2 - 10.1016/S2213-8587(15)70006-9

DO - 10.1016/S2213-8587(15)70006-9

M3 - Article

SN - 2213-8587

VL - 3

SP - 231

EP - 232

JO - The Lancet Diabetes & Endocrinology

JF - The Lancet Diabetes & Endocrinology

IS - 4

ER -